Shandong Sinobioway Biomedicine Co. Ltd. A | Ownership
Companies that own Shandong Sinobioway Biomedicine Co. Ltd. A
Huashang Fund Management Co., Ltd.
5,000,000
1.25%
2,005,107
0.24%
09/30/2017
Chang Xin Asset Management Co., Ltd.
3,249,935
0.81%
-1,299,208
0.15%
12/31/2017
The Vanguard Group, Inc.
506,060
0.13%
0
0%
07/31/2018
Guotai Junan Allianz Fund Management Co., Ltd.
296,826
0.07%
296,004
0.02%
12/31/2017
Penghua Fund Management Co., Ltd.
292,100
0.07%
292,100
0%
12/31/2017
SWS MU Fund Management Co., Ltd.
228,400
0.06%
-1,061,196
0.01%
12/31/2017
GF Fund Management Co., Ltd.
222,300
0.06%
-405,100
0%
12/31/2017
E Fund Management Co., Ltd.
199,950
0.05%
-49,000
0%
12/31/2017
Changsheng Fund Management Co., Ltd.
170,078
0.04%
-42,300
0.01%
12/31/2017
UBS SDIC Fund Management Co., Ltd.
136,100
0.03%
136,100
0.01%
12/31/2017
| Address |
Peking University Biological City
Beijing Shandong 100085
China
|
|
Employees
|
- |
| Website |
http://www.sdsinobioway.com |
| Updated |
07/08/2019 |
| Shandong Sinobioway Biomedicine Co., Ltd. engages in the research and development, manufacture, and sale of chemical raw materials, chemical and pharmaceutical products. Its products include pharmaceutical intermediates and pesticide intermediates. The company was founded on January 18, 2000 and is headquartered in Beijing, China. |
